Evidence map›Paper›PMID 12791897›Full record

ArticleJournal of clinical microbiology2003

Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.

Daniel J Diekema, Janet I Andrews, Holly Huynh, Paul R Rhomberg, Stella R Doktor, Jill Beyer, Virginia D Shortridge, Robert K Flamm, Ronald N Jones, Michael A Pfaller

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy).European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  4. Article
  5. Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2006
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Laboratory detection of group B Streptococcus for prevention of perinatal disease.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2004
    Review
  17. Article
  18. Article
  19. Distribution of serotypes and evaluation of antimicrobial susceptibility among human and bovine Streptococcus agalactiae strains isolated in Brazil between 1980 and 2006.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel J DiekemaDepartment of Internal Medicine, University of Iowa Colleges of Medicine and Public Health, Iowa City, Iowa 52242, USA. daniel-diekema@uiowa.edu
Janet I Andrews
Holly Huynh
Paul R Rhomberg
Stella R Doktor
Jill Beyer
Virginia D Shortridge
Robert K Flamm
Ronald N Jones
Michael A Pfaller

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulsed-field gel electrophoresis (PFGE) was performed on 122 neonatal bloodstream isolates of group B streptococci (GBS) to further examine the relationship between macrolide resistance and serotype V GBS (GBS-V). Over one-third (35%) of macrolide-resistant GBS belonged to a single PFGE subtype of GBS-V, which was also the most common GBS-V subtype noted in previous Centers for Disease Control and Prevention surveillance studies. Erm methylase (ermA and ermB) was the most common resistance mechanism detected, present in 12 of 20 macrolide-resistant GBS.

Indexed as

Molecular EpidemiologyAnti-Bacterial AgentsBacteremiaBacterial ProteinsBloodDrug Resistance, BacterialElectrophoresis, Gel, Pulsed-FieldHumansInfant, NewbornMacrolidesMethyltransferasesMicrobial Sensitivity TestsSerotypingStreptococcal InfectionsStreptococcus agalactiaeAnti-Bacterial AgentsBacterial ProteinsMacrolidesMethyltransferases

Identifiers

PMID12791897
PMCPMC156484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.